Plasmodium falciparum dhps and dhfr markers of resistance to sulfadoxine–pyrimethamine five years (2016–2020) after the implementation of seasonal malaria chemoprevention in Cameroon [version 1; peer review: 2 approved, 1 approved with reservations]

Background Antimalarial drug resistance is a major challenge in the fight against malaria. Cameroon implemented seasonal malaria chemoprevention (SMC) with sulfadoxine–pyrimethamine and amodiaquine (SPAQ) to over 1.5 million children aged 3–59 months from 2016, raising concerns whether drug pressure...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Palmer M. Netongo, Akindeh M. Nji, Peter Thelma N. Niba, Innocent M. Ali, Randolph Ngwafor, Calvino F. Tah, Germaine Ekoyol, William D. Nana, Jude D. Bigoga, Dorothy F. Ashu, Wilfried F. Mbacham, Christopher B. Tume, Pacome V. K. Tchuenkam, Jean Paul K. Chedjou, Lesley N. Ngum
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wellcome 2024-06-01
coleção:	Wellcome Open Research
Assuntos:	sulfadoxine–pyrimethamine drug resistance plasmodium falciparum chemoprevention Pfdhps Cameroon eng
Acesso em linha:	https://wellcomeopenresearch.org/articles/9-323/v1
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!